For the Month of July, 2011

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway, 2009, Vol 4-1 Pp. 28-35

Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)], 2011, Vol 6-1 Pp. 1-5

Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)], 2011, Vol 6-2 Pp. 164-165

The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery, 2008, Vol 3-3 Pp. 209-219

Anti-Cancer Therapies that Utilize Cell Penetrating Peptides, 2010, Vol 5-2 Pp. 99-108

Aldo-Keto Reductase Family 1 Member B1 Inhibitors: Old Drugs with New Perspectives, 2009, Vol 4-3 Pp. 246-253

Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2, 2011, Vol 6-2 Pp. 210-23

Metabolic Targeting of Malignant Tumors: Small-Molecule Inhibitors of Bioenergetic Flux, 2011, Vol 6-1 Pp. 6-14

Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies, 2011, Vol 6-2 Pp. 258-267

Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck, 2011, Vol 6-2 Pp. 246-257

For the Month of August, 2011

Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2, 2011, Vol 6-2 Pp. 210-236

Aldo-Keto Reductase Family 1 Member B1 Inhibitors: Old Drugs with New Perspectives, 2009, Vol 4-3 Pp. 246-253

Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)], 2011, Vol 6-1 Pp. 1-5

Anti-Cancer Therapies that Utilize Cell Penetrating Peptides, 2010, Vol 5-2 Pp. 99-108

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway, 2009, Vol 4-1 Pp. 28-35

Cell Cycle and Energy Metabolism in Tumor Cells: Strategies for Drug Therapy, 2011, Vol 6-1 Pp. 15-25

Metabolic Targeting of Malignant Tumors: Small-Molecule Inhibitors of Bioenergetic Flux, 2011, Vol 6-1 Pp. 6-14

Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy, 2011, Vol 6-2 Pp. 166-177

Editorial [Hot topic: Stresses, Death Receptors and Plasma Membrane (Guest Editors: Patrick Legembre and Faustino Mollinedo)], 2011, Vol 6-3 Pp. 271-273

Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck, 2011, Vol 6-2 Pp. 246-257

For the Month of September, 2011

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway, 2009, Vol 4-1 Pp. 28-35

Drug Combinations Enhancing the Antineoplastic Effects of Erlotinib in High-Grade Glioma, 2011, Vol 6-3 Pp. 384-394

Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion, 2011, Vol 6-3 Pp. 311-323

Editorial [Hot topic: Stresses, Death Receptors and Plasma Membrane (Guest Editors: Patrick Legembre and Faustino Mollinedo)], 2011, Vol 6-3 Pp. 271-273

Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine, 2009, Vol 4-1 Pp. 54-72

Ceramide in Chemotherapy of Tumors, 2011, Vol 6-3 Pp. 284-293

Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)], 2011, Vol 6-1 Pp. 1-5

Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?, 2011, Vol 6-2 Pp. 196-209

Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review, 2011, Vol 6-3 Pp. 367-372

Anti-Cancer Therapies that Utilize Cell Penetrating Peptides, 2010, Vol 5-2 Pp. 99-108